S.I. No. 3/2024 - European Union (Clinical Trials on Medicinal Products for Human Use) (Amendment) Regulations 2024 Skip to content Disclaimer Feedback Helpdesk Gaeilge Léim go dtí an t-ábhar Séanadh Aiseolas Deasc chabhrach English Gaeilge English Produced by the Office of the Attorney General Táirgthe ag Oifig an Ard-Aighne Home Legislation Acts of the Oireachtas Statutory Instruments Pre-1922 Legislation Constitution External Resources Bills (Houses of the Oireachtas) Iris Oifigiúil / Official Gazette Revised Acts (LRC) Classified List of Legislation (LRC) Translations (acts.
- ie)Translations (Houses of the Oireachtas) Government Publications for Sale EU Law (EUR-Lex) FAQ Disclaimer Feedback Helpdesk Search Baile Reachtaíocht Achtanna an Oireachtais Ionstraimí Reachtúla Reachtaíocht Réamh-1922 Bunreacht Acmhainní Seachtracha Billí (Tithe an Oireachtais) Iris Oifigiúil Achtanna Athbhreithnithe (CAD) (An Coimisiún um Athchóiriú an Dlí) Liosta Rangaithe Reachtaíochta Aistriúcháin (achtanna.
- ie)Aistriúcháin (Tithe an Oireachtais) Foilseacháin Rialtais ar Díol Dlí AE (EUR-Lex) CCanna (Ceisteanna Coitianta) Séanadh Aiseolas Deasc chabhrach Cuardach TitleTeideal Year(
- s)or rangeBliain nó blianta nó raon TypeCineál All Legislation Acts Statutory Instruments Advanced SearchCuardach Casta HomeBaile Statutory InstrumentsIonstraimí Reachtúla 2024 S.I. No. 3/2024 - European Union (Clinical Trials on Medicinal Products for Human Use) (Amendment) Regulations 2024 S.I. No. 3/2024 - European Union (Clinical Trials on Medicinal Products for Human Use) (Amendment) Regulations 2024 AmendmentsLeasuithe Download PDF Íoslódáil PDF Notice of the making of this Statutory Instrument was published in “Iris Oifigiúil” of 12th January, 2024. I, STEPHEN DONNELLY, Minister for Health, in exercise of the powers conferred on me by section 3 of the European Communities Act 1972 (No. 27 of 1972) and for the purpose of giving further effect to Regulation (EC) No. 536/2014 of 16 April 20141 , hereby make the following regulations: 1.
(1)These Regulations may be cited as the European Union (Clinical Trials on Medicinal Products for Human Use) (Amendment) Regulations 2024.
(2)The Principal Regulations, the European Union (Clinical Trials on Medicinal Products for Human Use) (Principal) (Amendment) Regulations 2022 ( S.I. No. 418 of 2022 ) and these Regulations may be cited together as the European Union (Clinical Trials on Medicinal Products for Human Use) Regulations 2022 to
- In these Regulations— “Principal Regulations” means the European Union (Clinical Trials on Medicinal Products for Human Use) (Principal) Regulations 2022 ( S.I. No. 99 of 2022 ); “Regulations of 2022” means the European Union (Clinical Trials on Medicinal Products for Human Use) (Principal) (Amendment) Regulations 2022 ( S.I. No. 727 of 2022 ).
- The Principal Regulations are amended by substituting for Regulation 61A (inserted by Regulation 2 of the Regulations of 2022) the following: “61A. A notice of amendment under Regulation 21
(3)of the European Communities (Clinical Trials on Medicinal Products for Human Use) Regulations 2004 to which Regulation 61(a) applies shall be made to the National Office and, in the case of commercial trials, a fee of €400 shall apply in connection with each such notification.”.
- The Regulations of 2022 are revoked. GIVEN under my Official Seal, 8 January,
- STEPHEN DONNELLY, Minister for Health. EXPLANATORY NOTE (This note is not part of the Instrument and does not purport to be a legal interpretation.) These Regulations amend the European Union (Clinical Trials on Medicinal Products for Human Use) (Principal) Regulations 2022 to update the fees payable to the National Office in respect of applications coming under the remaining transitional provisions that apply in respect of the repeal of the European Communities (Clinical Trials on Medicinal Products for Human Use) Regulations
- 1 OJ No. L 158, 27.5.2014, p.
- Privacy Statement Accessibility European Legislation Identifier (PDF) Open Data License Ráiteas Príobháideachais Inrochtaineacht Aitheantóir Eorpach Reachtaíochta (ELI) Ceadúnas Sonraí Oscailte Liosta Fianán © Government of Ireland. Oireachtas Copyright Material is reproduced with the permission of the Houses of the Oireachtas © Rialtas na hÉireann. Atáirgtear ábhar faoi Chóipcheart le cead ó Thithe an Oireachtais